Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03704584 · ClinicalTrials.gov registry record · Phase 4
Corticosteroid(CS) + Lido or Corticosteroid(CS) Alone
A Phase 4 study, sponsored by Emory University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 62
- Enrollment target
NCT03704584 is a Phase 4 study that was terminated before completion, run by Emory University. The registered enrollment target is 62 participants.
The verdict
NCT03704584, a Phase 4 study, was terminated before completion, sponsored by Emory University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 62 participants
- Enrollment target
Study Summary
The clinical trial is a randomized control trial to compare the efficacy of a combined lidocaine and corticosteroid (CS) injection versus a corticosteroid injection (CS) alone on pain, range of motion, and patient reported outcomes for the treatment of common upper extremity tendinopathies and nerve entrapments that are often treated with a combination of these injectates.
Interventions
- DRUG Treatment Group: Corticosteroid injection
- DRUG Control Group (corticosteroid alone)
- DRUG Treatment Group: Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2019-05-14 |
| Est. Completion | 2020-01-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03704584
The ClinicalTrials.gov registry entry for NCT03704584 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Treatment Group: Corticosteroid injection is the first listed.
NCT03704584 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03704584 about?
NCT03704584 is a clinical study titled "Corticosteroid(CS) + Lido or Corticosteroid(CS) Alone". The clinical trial is a randomized control trial to compare the efficacy of a combined lidocaine and corticosteroid (CS) injection versus a corticosteroid injection (CS) alone on pain, range of motion, and patient reported outcomes for the treatment of common upper extremity tendinopathies and nerve...
What is the current status of trial NCT03704584?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 62 participants. The study started on 2019-05-14. Estimated completion is 2020-01-14.
What interventions are being tested in trial NCT03704584?
The interventions under investigation include: Treatment Group: Corticosteroid injection (DRUG), Control Group (corticosteroid alone) (DRUG), Treatment Group: Lidocaine (DRUG).
Who is sponsoring clinical trial NCT03704584?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.